Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Neurodegener Dis. 2015 Nov 10;16(0):39–43. doi: 10.1159/000438925

Figure 1. Hippocampal levels of eEF1A are diminished in AD cases compared to age-matched controls.

Figure 1

(A) Representative Western blot shows reduced hippocampal eEF1A levels in AD patients (AD), compared to age-matched controls (CT). Cerebellum and midfrontal gyrus levels are similar in AD and control samples. (B) Cumulative data based on densitometric analysis for eEF1A Western blot experiments (n=10) are shown in bar graph. Levels of eEF1A are significantly decreased in hippocampi of AD patients compared to those of age-matched controls. Independent unpaired t-test, **p<0.01.